Zenrelia (ilunocitinib) Tablets for Dogs - 4.8 mg

Description: Zenrelia™ is indicated for the control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs.

Product: Zenrelia™ Tablets

For: Dogs (at least 12 months old, weighing 6.7 lbs or more)

Generic Name: Ilunocitinib

Brand Names: Zenrelia™

Drug Class: Janus Kinase (JAK) Inhibitor, Antipuritic, Immunomodulator

Manufacturer: Elanco

Product Description & Form: Zenrelia™ 4.8 mg Tablets: 11 mm, yellow, oval tablet, scored in half, no imprint. (NDC 58198–5536–01, 58198–5536–03) Zenrelia™ 4.8 mg Tablets Zenrelia™ 6.4 mg Tablets: 12 mm, yellow, oval tablet, scored in half, no imprint. (NDC 58198–5537–01, 58198–5537–03) Zenrelia™ 6.4 mg Tablets Zenrelia™ 8.5 mg Tablets: 13 mm, yellow, oval tablet, scored in half, no imprint. (NDC 58198–5538–01, 58198–5538–03) Zenrelia™ 8.5 mg Tablets Zenrelia™ 15 mg Tablets: 16 mm, yellow, oval tablet, scored in half, no imprint. (NDC 58198–5539–01, 58198–5539–03)Zenrelia™ 15 mg Tablets

Benefits:

A hypoallergenic, unflavored, oral tablet

Once daily administration, with or without food

No loading or tapering, just once a day from the start

Janus Kinase (JAK) inhibitor designed to disrupt cytokine signaling pathways that trigger itch and inflammation related to canine allergic and atopic dermatitis

Reduces lesions and inflammation, improving skin condition

Works fast: visible improvements in allergic itch from day one